Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts

International Immunopharmacology

Volumn 3, Issue 12, 2003, Pages 1685-1697

  Jeong, Ji Cheon ^a   Kang, Sung Koo ^a   Youn, Cheol Ho ^a   Jeong, Chang Whan ^a   Kim, Hyung Min ^b   Lee, Young Choon ^c   Chang, Young Chae ^d   Kim, Cheorl Ho ^a  

^a Dongguk University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Dong A University   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

Biosynthesis; Bone resorption; Cathepsin; Drynariae Rhizoma; Osteoclast; Processing; Protease inhibitor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROMINE DERIVATIVE; CALPHOSTIN C; CATHEPSIN K; CYSTEINE PROTEINASE; DRYNARIAE RHIZOMA EXTRACT; ENZYME PRECURSOR; PLANT EXTRACT; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL CULTURE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG POTENCY; DRYNARIAE RHIZOMA; ENZYME INHIBITION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; INHIBITION KINETICS; LONG BONE; MALE; MITOCHONDRION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

DRYNARIA FORTUNEI;

EID: 0141749336     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.08.003     Document Type: Article

References (57)

1. Ettinger B., Genant H.K., Cann C.E. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann. Intern. Med. 106:1987;40-45.
2. Cheng J.T. Drug therapy in Chinese traditional medicine. J. Clin. Pharmacol. 40:2000;445-450.
3. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol. Sci. 16:1995;182-187.
4. Yuan R., Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 86:2000;191-198.
5. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:1991;175-192.
6. Morris H.A., Need A.G., Horowitz M., O'Leughlin P.D., Nordin B.E.C. Calcium adsorption in normal and osteoporotic postmenopausal women. Calcif. Tissue Int. 48:1991;240-243.
7. Agnusdei D., Comporeaale A., Zacchei F., Gennari C., Baroni M., Costi D.et al. Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr. Ther. Res. 51:1992;82-91.
8. Xiu R.J. Microcirculation and traditional Chinese medicine. JAMA. 269:1988;1755-1757.
9. Koyama T. Osteoporosis with Kampo treatment [in Japanese]. Sanfujinka Chiryo. 63:1991;203-207.
10. Terasawa K. Kampo: Japanese-oriental medicine. 1993;K.K. Standard McIntyre, Tokyo, Japan.
11. Phillipson J.D., Anderson L.A. Ethnopharmacology and Western medicine. J. Ethnopharmacol. 25:1989;61-72.
12. Sun J.S., Lin C.Y., Dong G.C., Sheu S.Y., Lin F.H., Chen L.T.et al. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials. 23:2002;3377-3385.
13. Ma K.C., Zhu T.Y., Wang F.X. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Am. J. Chin. Med. 24:1996;77-82.
14. Liu H.C., Chen R.M., Jian W.C., Lin Y.L. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J. Formos. Med. Assoc. 100:2001;383-388.
15. Shi X.C. Chinese-English terminology of traditional Chinese medicine. 1983;71-98 Hunan Science Publishing, China.
16. Hong S.-N. PhD Thesis, Dongguk University, Kyungju, Korea; 2001.
17. Falgueyret J.P., Oballa R.M., Okamoto O., Wesolowski G., Aubin Y., Rydzewski R.M.et al. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsin K and L. J. Med. Chem. 44:2001;94-104.
18. Delaisse J.M., Eeckout Y., Vaes G. Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem. J. 192:1980;365-368.
19. Votta B.J., Levy M.A., Badger A., Dodds R.A., James I.E., Thompson S.et al. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vivo and in vitro. J. Bone Miner. Res. 12:1997;1396-1406.
20. Iwata Y., Mort J.S., Tateishi H., Lee E.R. Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. Arthritis Rheum. 40:1997;499-509.
21. Yagel S., Warner A.H., Nellans H.N., Lala P.K., Waghorne C., Denhardt D.T. Suppression by cathepsin L inhibitors of the invasion of the amnion membranes by murine cancer cells. Cancer Res. 49:1989;553-3557.
22. Chambers A.F., Colella R., Denhardt D.R., Wilson S.M. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinog. 5:1992;238-245.
23. Esser R.E., Angelo R.A., Murphey M.D., Watts L.M., Thornburg L.P., Palmer J.T.et al. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum. 37:1994;236-247.
24. Lenarcic B., Gabrijelcic D., Rozman B., Drobnic-Kosorok M., Turk V. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol. Chem. Hoppe-Seyler. 369:1988;257-261.
25. Gelb B.D., Moissoglu K., Zhang J., Martgnetti J.A., Bromme D., Desnick R.J. Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. Biochem. Mol. Med. 59:1996;200-206.
26. Tezuka K., Tezuka Y., Maejima M., Sato T., Nemoto K., Kamioka H.et al. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269:1994;1106-1109.
27. Li Y.P., Alexander M., Wucherpfennig A.L., Yelick P., Chen W., Stashenko P. Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J. Bone Miner. Res. 10:1995;1197-1202.
28. Rantakokko J., Aro H.T., Savontaus M., Vuorio E. Mouse cathepsin KL cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett. 393:1996;307-313.
29. Li Y.P., Chen W. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. J. Bone Miner. Res. 14:1999;487-499.
30. 2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J. Biol. Chem. 271:1996;2126-2132.
31. Drake F.H., Dodds F.A., James I.E., Connor J.R., DeBouck C., Richardson S.et al. Cathepsin K, but not B, L or S is abundantly expressed in human osteoclasts. J. Biol. Chem. 271:1996;12511-12516.
32. Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T. Molecular cloning of human cDNA for cathepsin K. Novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206:1995;89-96.
33. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H.et al. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269:1994;1100-1109.
34. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S.et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273:1998;32347-32352.
35. Kafienah W., Bromme D., Buttle D.J., Croucher L.J., Holander A.P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple complex. Biochem. J. 331:1998;727-732.
36. Rieman D.J., Mcclung H.A., Dodds R.A., Hwang S.M., Lark M.W., Holmes S. et al. Biosynthesis and processing of cathepsin K in cultured human osteoblasts. Bone. 28:2001;282-289.
37. Clohisy J.C., Connolly T.J., Bergman K.D., Quinn C.O., Patridge N.C. Prostanoid-induced expression of matrix mettaloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells. Endocrinology. 135:1994;1447-1453.
38. Delaisse J.M., Eeckout Y., Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 12:1984;441-447.
39. Felix R., Cecchini M.G., Fleisch H. Macrophage colonystimulating factor restores in vivo bone resorption in the op/op os-teopetrotic mouse. Endocrinology. 127:1990;2592-2594.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
41. Kim Y.J., Kim K.S., Chang J.E., Lee Y.C., Ko J.H., Chung T.W.et al. Analysis of 5′-flanking and promoter region of human N-acetylglucosaminyltransferase gene. Gene. 170:1996;281-283.
42. Tsurukai T., Takahashi N., Jimi E., Nakamura I., Udagawa N., Nogimori K.et al. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time. J. Cell. Physiol. 177:1998;26-35.
43. Takahashi N., Udagawa N., Akatsu T., Tanaka H., Shionome M., Suda T. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6:1991;977-985.
44. Evans D.B., Bunning R.A.D., Russell R.G.G. The effects of recombinant human interleukin-1 on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem. Biophys. Res. Commun. 166:1990;208-216.
45. Raiz L.G., Niemann I. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology. 85:1969;446-452.
46. Hong H.T., Kim H.J., Kim D.W., Lee Y.C., ParK Y.G., Kim H.M.et al. Inhibitory effect of a Korean traditional medicine, Honghwain-Jahage (water extracts of Carthamus tinctorius L. seed and Homminis placenta) on interleukin-1-mediated bone resorption. J. Ethnopharmacol. 43:2002;11-16.
47. James I.E., Lark M.W., Zembryki D., Lee-Rykaczewski E., Hwang S.M., Tomaszek T.A.et al. Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents. J. Bone Miner. Res. 14:1999;1562-1569.
48. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
49. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
50. Chung T.W., Moon S.K., Lee Y.C., Kim J.G., Ko J.H., Kim C.H. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch. Biochem. Biophys. 408:2002;147-154.
51. Nakamura I., Takahashi N., Sasaki T., Tanaka S., Udagawa N., Murakami H.et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. Fed. Eur. Bone Soc. Lett. 361:1995;79-84.
52. Huang H.F., You J.S. The use of Chinese herbal medicine on experimental fracture healing. Am. J. Chin. Med. 25:1997;351-356.
53. Liu H.C., Chen R.M., Jian W.C., Lin Y.L. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J. Formos. Med. Assoc. 100:2001;383-388.
54. Nakajima Y., Pfeffer S.R. Phosphoinositol 3-kinase is not required for recycling of mannose-6-phosphate receptors from late endosomes to the trans-Golgi network. Mol. Cell. Biol. 8:1997;582-677.
55. Delaisse J.M., Eeckout Y., Vaes G. Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem. J. 192:1980;365-368.
56. Lakkakorpi P.T., Wesolowski G., Zimolo Z., Rodan G.A., Rodan S.B. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Exp. Cell Res. 237:1997;296-306.
57. Nakamura I., Sasaki T., Tanaka S., Takahashi N., Jimi E., Kurokawa T.et al. PI3 kinase is involved in ruffled border formation in osteoclasts. J. Cell. Physiol. 172:1997;230-239.